FindMyKOL
Clinical trialNCT03799705CompletedObservational

Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway

NCT03799705 is an observational study sponsored by Mayo Clinic. As of 21 Nov 2026, it is completed. It studies Congenital Malformation and Vacterl Association. The registry lists an enrollment of 132 participants at 1 site in 1 country. The registry lists a start date of 1 Dec 2019 and a primary completion date of 1 Dec 2022.

SponsorMayo Clinic →Enrollment132Congenital MalformationVacterl Association
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03799705
FieldValue
Registry IDNCT03799705
StatusCompleted
Study typeObservational study
Lead sponsorMayo Clinic
Enrollment132
Registered sites1
Countries1
ConditionsCongenital Malformation and Vacterl Association
Start1 Dec 2019
Primary completion1 Dec 2022
Study completion1 Dec 2022
Last update posted19 Apr 2024

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Researchers are trying to identify versions of genes as well as factors in subjects blood associated with certain types of congenital malformations(CMs). This study will help the researchers to better understand family traits that contribute to CMs.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Minnesota, United States1 site
  • Mayo Clinic

    Rochester

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 1 siteMN1WisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03799705

Each answer restates registry values shown on this page.

What is NCT03799705?

NCT03799705 is an observational study sponsored by Mayo Clinic. It studies Congenital Malformation and Vacterl Association.

Who leads NCT03799705?

The registry names Myra Wick, MD PhD (principal investigator, Mayo Clinic) as the overall official.

Where does NCT03799705 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT03799705 end?

The registry lists a primary completion date of 1 Dec 2022 and a study completion date of 1 Dec 2022. The sponsor last updated the record on 19 Apr 2024.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.